211 related articles for article (PubMed ID: 8558701)
1. Elevated interleukin-8 levels in the urine of children with renal scarring and/or vesicoureteral reflux.
Haraoka M; Senoh K; Ogata N; Furukawa M; Matsumoto T; Kumazawa J
J Urol; 1996 Feb; 155(2):678-80. PubMed ID: 8558701
[TBL] [Abstract][Full Text] [Related]
2. Urine interleukin-8 as a marker of vesicoureteral reflux in infants.
Galanakis E; Bitsori M; Dimitriou H; Giannakopoulou C; Karkavitsas NS; Kalmanti M
Pediatrics; 2006 May; 117(5):e863-7. PubMed ID: 16585276
[TBL] [Abstract][Full Text] [Related]
3. Urine interleukin-1beta in children with acute pyelonephritis and renal scarring.
Sheu JN; Chen MC; Cheng SL; Lee IC; Chen SM; Tsay GJ
Nephrology (Carlton); 2007 Oct; 12(5):487-93. PubMed ID: 17803473
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of urinary interleukin-6 in children with reflux nephropathy.
Wang J; Konda R; Sato H; Sakai K; Ito S; Orikasa S
J Urol; 2001 Jan; 165(1):210-4. PubMed ID: 11125408
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-6 and interleukin-8 levels in the urine of children with renal scarring.
Tramma D; Hatzistylianou M; Gerasimou G; Lafazanis V
Pediatr Nephrol; 2012 Sep; 27(9):1525-30. PubMed ID: 22527530
[TBL] [Abstract][Full Text] [Related]
6. Renal parenchymal damage in intermediate and high grade infantile vesicoureteral reflux.
Mohanan N; Colhoun E; Puri P
J Urol; 2008 Oct; 180(4 Suppl):1635-8; discussion 1638. PubMed ID: 18708232
[TBL] [Abstract][Full Text] [Related]
7. Renal scarring and urinary tract infection after successful endoscopic correction of vesicoureteral reflux.
Chertin B; Natsheh A; Fridmans A; Shenfeld OZ; Farkas A
J Urol; 2009 Oct; 182(4 Suppl):1703-6. PubMed ID: 19692032
[TBL] [Abstract][Full Text] [Related]
8. Urinary cytokines as markers of reflux nephropathy.
Ninan GK; Jutley RS; Eremin O
J Urol; 1999 Nov; 162(5):1739-42. PubMed ID: 10524926
[TBL] [Abstract][Full Text] [Related]
9. Renal scarring in familial vesicoureteral reflux: is prevention possible?
Pirker ME; Colhoun E; Puri P
J Urol; 2006 Oct; 176(4 Pt 2):1842-6; discussion 1846. PubMed ID: 16945668
[TBL] [Abstract][Full Text] [Related]
10. Relationship between serum and urine interleukin-6 elevations and renal scarring in children with acute pyelonephritis.
Sheu JN; Chen MC; Chen SM; Chen SL; Chiou SY; Lue KH
Scand J Urol Nephrol; 2009; 43(2):133-7. PubMed ID: 18972261
[TBL] [Abstract][Full Text] [Related]
11. Urinary levels of interleukin-6 and interleukin-8 in patients with vesicoureteral reflux and renal parenchymal scar.
Gokce I; Alpay H; Biyikli N; Unluguzel G; Dede F; Topuzoglu A
Pediatr Nephrol; 2010 May; 25(5):905-12. PubMed ID: 20084405
[TBL] [Abstract][Full Text] [Related]
12. Surgical management of grades III and IV primary vesicoureteral reflux in children with and without acute pyelonephritis as breakthrough infections: a comparative analysis.
Yu TJ; Chen WF
J Urol; 1997 Apr; 157(4):1404-6. PubMed ID: 9120964
[TBL] [Abstract][Full Text] [Related]
13. Progression of chronic kidney disease in children with vesicoureteral reflux: the North American Pediatric Renal Trials Collaborative Studies Database.
Novak TE; Mathews R; Martz K; Neu A
J Urol; 2009 Oct; 182(4 Suppl):1678-81. PubMed ID: 19692051
[TBL] [Abstract][Full Text] [Related]
14. Followup study of renal function in children with reflux nephropathy after resolution of vesicoureteral reflux.
Konda R; Sakai K; Ota S; Takeda A; Orikasa S
J Urol; 1997 Mar; 157(3):975-9. PubMed ID: 9072628
[TBL] [Abstract][Full Text] [Related]
15. Vesicoureteral reflux associated renal damage: congenital reflux nephropathy and acquired renal scarring.
Peters C; Rushton HG
J Urol; 2010 Jul; 184(1):265-73. PubMed ID: 20483150
[TBL] [Abstract][Full Text] [Related]
16. Familial vesicoureteral reflux--is screening beneficial?
Menezes M; Puri P
J Urol; 2009 Oct; 182(4 Suppl):1673-7. PubMed ID: 19692047
[TBL] [Abstract][Full Text] [Related]
17. Relationship among vesicoureteral reflux, urinary tract infection and renal damage in children.
Swerkersson S; Jodal U; Sixt R; Stokland E; Hansson S
J Urol; 2007 Aug; 178(2):647-51; discussion 650-1. PubMed ID: 17574623
[TBL] [Abstract][Full Text] [Related]
18. Changing concepts concerning the management of vesicoureteral reflux.
Herndon CD; DeCambre M; McKenna PH
J Urol; 2001 Oct; 166(4):1439-43. PubMed ID: 11547107
[TBL] [Abstract][Full Text] [Related]
19. Urinary L-FABP as a marker of vesicoureteral reflux in children: could it also have a protective effect on the kidney?
Benzer M; Tekin Neijmann S; Gültekin ND; Uluturk Tekin A
Int Urol Nephrol; 2017 Jan; 49(1):1-12. PubMed ID: 27550232
[TBL] [Abstract][Full Text] [Related]
20. Magnetic resonance imaging detected renal volume reduction in refluxing and nonrefluxing kidneys.
Chang SL; Caruso TJ; Shortliffe LD
J Urol; 2007 Dec; 178(6):2550-4. PubMed ID: 17937957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
